Successful treatment of Hailey-Hailey disease with acitretin.

J Drugs Dermatol. 2007 Jul;6(7):734-6. Berger EM, Galadari HI, Gottlieb AB. Source Department of Dermatology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA. [email protected] Abstract Hailey-Hailey disease is an autosomal dominant skin condition characterized by waxing and waning … Read More

Novel cutaneous uses for botulinum toxin type A.

J Cosmet Dermatol. 2006 Sep;5(3):268-72. Bansal C, Omlin KJ, Hayes CM, Rohrer TE. Source Drexel University College of Medicine, Philadelphia, PA 19144, USA. [email protected] Abstract Botulinum toxin type A is a neurotoxin produced by the bacterium Clostridium botulinum which causes a flaccid muscle paralysis. … Read More

Case reports of etanercept in inflammatory dermatoses.

 Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S139-42. Norman R, Greenberg RG, Jackson JM. Abstract Skin disfigurations and pruritus can pose severe threats to quality of life, and treatment options for patients with recalcitrant diseases are limited. Tumor necrosis factor alpha, a proinflammatory cytokine, … Read More

Botulinum toxin in dermatology – beyond wrinkles and sweat.

J Cosmet Dermatol. 2005 Dec;4(4):223-7. Wollina U, Konrad H, Petersen S. Source Department of Dermatology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany. [email protected] Abstract Botulinum toxin (BTX) types A and B have been used with success in cosmetic dermatology and hyperhidrosis treatment. The present … Read More

Severe impairment of quality of life in Hailey-Hailey disease.

Acta Derm Venereol. 2005;85(2):132-5. Gisondi P, Sampogna F, Annessi G, Girolomoni G, Abeni D. Source Istituto Dermopatico dell’Immacolata, IRCCS, 00167 Rome, Italy. Abstract Hailey-Hailey disease (a skin fragility disorder) runs a chronic course and may cause important disability. However, little has been formally investigated concerning … Read More